Written Question · S5W-16071 · Session 5
which research projects relating to Parkinson's disease it has funded since 1999, and what the funding commitment was to each project.
The question
To ask the Scottish Government which research projects relating to Parkinson's disease it has funded since 1999, and what the funding commitment was to each project.
The answer
Researchers can apply to the Chief Scientist Office for funding. The CSO's Translational Clinical Studies Committee and the Health Improvement, Protection and Services Research Committees each meet twice per year to consider funding applications. Details of the application process are published on the CSO website.
http://www.cso.scot.nhs.uk/funding-2/
Research proposals in Parkinson’s Disease (including research into the underlying mechanisms and causes, diagnosis, prevention, disease-modifying treatments, care pathways etc.) are welcomed. In common with all other applications, any such proposals would be subject to the Chief Scientist Office’s standard independent expert review process.
Since 1999 the following projects in Parkinson's Disease have been funded by CSO
Identification of prognostic factors and development of prognostic models in Parkinson's disease using long-term data from a large incidence-based cohort
Funding commitment £194,985
Improving predictions of prognosis in Parkinson's: moving from intensive small-scale studies to large and reliable routinely-collected datasets
Funding commitment £20,000
The Chief Scientist Office has an active programme of co-funding research with 3rd sector organisations. Officials from CSO are currently in discussion with Parkinson's UK around potential areas of collaboration.
The Scottish Government provides annual funding of over £490,000 for the Scottish Dementia and Neuroprogressive Disease Research Network. The network supports a wide range of research studies in Neuroprogressive disease, including Parkinson’s.
http://www.cso.scot.nhs.uk/funding-2/
Research proposals in Parkinson’s Disease (including research into the underlying mechanisms and causes, diagnosis, prevention, disease-modifying treatments, care pathways etc.) are welcomed. In common with all other applications, any such proposals would be subject to the Chief Scientist Office’s standard independent expert review process.
Since 1999 the following projects in Parkinson's Disease have been funded by CSO
Identification of prognostic factors and development of prognostic models in Parkinson's disease using long-term data from a large incidence-based cohort
Funding commitment £194,985
Improving predictions of prognosis in Parkinson's: moving from intensive small-scale studies to large and reliable routinely-collected datasets
Funding commitment £20,000
The Chief Scientist Office has an active programme of co-funding research with 3rd sector organisations. Officials from CSO are currently in discussion with Parkinson's UK around potential areas of collaboration.
The Scottish Government provides annual funding of over £490,000 for the Scottish Dementia and Neuroprogressive Disease Research Network. The network supports a wide range of research studies in Neuroprogressive disease, including Parkinson’s.
In the Official Report
No contribution in the Official Report cites S5W-16071 by reference.